Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crossover study of on-demand versus daily Truvada for HIV pre-exposure prophylaxis in high-risk men who have sex with men
ChiCTR1800016100Phase 4Not yet recruiting
- Sponsor
- Stanley Ho Centre for Emerging Infectious Diseases
- Start
- Jan 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Stanley Ho Centre for Emerging Infectious Diseases. Primary endpoints: Adherence rate and Coverage of unprotected sex episodes by PrEP. Planned start Jan 1990; status: not yet recruiting.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR1800016100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016100.